Original, source-linked analysis with study design, model boundaries and limitations kept visible. Research findings are not device-wide promises.
For professional education and institutional evaluation. Published research is not authorization for use in Mexico or another country. Confirm the exact device, local registration, current instructions and institutional permissions before clinical use.
Source-based editorial analysis by OMNIBOT MX. No independent medical reviewer is asserted. Read the original publication and assess applicability with your institution.
This is early human feasibility evidence under a specific protocol. Network quality and bedside backup are part of that context, not transferable guarantees. A hospital considering remote surgery needs its own technical validation, clinical safeguards and regulatory approvals.
Sheng Tai, Ye Wang · International Journal of Surgery; 111(10):6678–6687
18 patients across four hospitals; single-arm phase I trial.
Small uncontrolled cohort and supported network conditions; selection and surgeon experience limit generalizability. No authorization for routine or cross-border use follows.
The comparison is remote versus local operation on the study platform, not superiority over another robot. It supports short-term reliability within the specified margin and protocol. Credible intervals, withdrawal and short follow-up remain important when interpreting applicability.
Ye Wang, Dan Xia · BMJ; 392:e083588
72 randomized patients; 36 per arm, five centers.
Small cohort, 12.5% withdrawal, expert-selected margin and 4–6-week follow-up. No long-term or economic conclusions.